Related Experiment Video
Updated: Mar 17, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
A BMI >35 does not protect patients undergoing cardiac bypass surgery from red blood cell transfusion
Linda B Mongero1, Eric A Tesdahl1, Al H Stammers1
11 Medical Department of Specialty Care, Nashville, TN, USA.
Insights
Obesity may reduce the need for red blood cell (RBC) transfusions during coronary artery bypass graft (CABG) surgery. However, this protective effect diminishes with increasing obesity, and other factors influence transfusion rates.
Area of Science:
- Cardiovascular Surgery
- Transfusion Medicine
- Obesity Research
Background:
- The relationship between obesity and blood product transfusion during coronary artery bypass graft (CABG) surgery remains unclear.
- Understanding this association is crucial for optimizing perioperative management and resource allocation.
Purpose of the Study:
- To investigate the impact of varying degrees of obesity on the requirement for intraoperative red blood cell (RBC) transfusion in patients undergoing CABG.
- To identify whether obesity acts as an independent predictor of transfusion risk in this surgical population.
Main Methods:
- Analysis of a large multi-institutional dataset comprising 45,200 non-reoperative CABG procedures.
- Statistical modeling, including logistic regression, to assess the association between body mass index (BMI) categories and RBC transfusion rates.
- Control for known confounding variables influencing transfusion requirements.
Main Results:
- A body mass index (BMI) in the obese I category was associated with a statistically significant 9.9% decrease in transfusion risk.
- Overweight and mild obesity (obese I) demonstrated a protective effect against intraoperative blood transfusion during cardiopulmonary bypass (CPB).
- Logistic regression indicated that confounding factors accounted for a significant portion of the observed reduction in transfusion rates among obese patients, and no linear effect of increasing BMI on transfusion risk was found.
Conclusions:
- Overweight and mild obesity may play a protective role in reducing intraoperative RBC transfusions in CABG patients.
- The lack of a consistent, dose-dependent relationship between increasing BMI and transfusion risk is a novel finding.
- Further research is warranted to elucidate the complex interplay between obesity, surgical factors, and transfusion requirements in CABG surgery.
Abstract:
The effect of obesity on allogeneic intraoperative blood product transfusion in patients undergoing coronary artery bypass graft surgery (CABG) is poorly understood. We analyzed the influence of obesity on the risk of intraoperative red blood cell (RBC) transfusion among 45,200 consecutive non-reoperative CABG procedures from a multi-institutional perfusion database. A body mass index (BMI) in obese I category was associated with a 9.9% decrease in transfusion risk (p<0.05). Compared to patients with a normal BMI, obese I and obese III patients do not have any change in the relative risk of RBC transfusion. Overweight and mild obesity have a protective role in reducing intraoperative blood transfusion during cardiopulmonary bypass (CPB) surgery. However, logistic regression analysis showed that much of the observed reduction in transfusion rates for obese patients can be accounted for by other known confounds. The lack of a linear effect of increasing BMI on blood transfusion risk is a novel finding and warrants further investigation.
Related Concept Videos
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Drug Dosing: Obese Patients

